» Articles » PMID: 29665803

Plasmodium Vivax and Plasmodium Falciparum Infection Dynamics: Re-infections, Recrudescences and Relapses

Overview
Journal Malar J
Publisher Biomed Central
Specialty Tropical Medicine
Date 2018 Apr 19
PMID 29665803
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In malaria endemic populations, complex patterns of Plasmodium vivax and Plasmodium falciparum blood-stage infection dynamics may be observed. Genotyping samples from longitudinal cohort studies for merozoite surface protein (msp) variants increases the information available in the data, allowing multiple infecting parasite clones in a single individual to be identified. msp genotyped samples from two longitudinal cohorts in Papua New Guinea (PNG) and Thailand were analysed using a statistical model where the times of acquisition and clearance of each clone in every individual were estimated using a process of data augmentation.

Results: For the populations analysed, the duration of blood-stage P. falciparum infection was estimated as 36 (95% Credible Interval (CrI): 29, 44) days in PNG, and 135 (95% CrI 94, 191) days in Thailand. Experiments on simulated data indicated that it was not possible to accurately estimate the duration of blood-stage P. vivax infections due to the lack of identifiability between a single blood-stage infection and multiple, sequential blood-stage infections caused by relapses. Despite this limitation, the method and data point towards short duration of blood-stage P. vivax infection with a lower bound of 24 days in PNG, and 29 days in Thailand. On an individual level, P. vivax recurrences cannot be definitively classified into re-infections, recrudescences or relapses, but a probabilistic relapse phenotype can be assigned to each P. vivax sample, allowing investigation of the association between epidemiological covariates and the incidence of relapses.

Conclusion: The statistical model developed here provides a useful new tool for in-depth analysis of malaria data from longitudinal cohort studies, and future application to data sets with multi-locus genotyping will allow more detailed investigation of infection dynamics.

Citing Articles

Recurrence patterns and evolution of submicroscopic and asymptomatic Plasmodium vivax infections in malaria-endemic areas of the Peruvian Amazon.

Garcia Castillo S, Abanto Alvarez C, Rosas-Aguirre A, Acosta C, Corder R, Gomez J PLoS Negl Trop Dis. 2024; 18(10):e0012566.

PMID: 39480785 PMC: 11527163. DOI: 10.1371/journal.pntd.0012566.


Elevated Inflammation Associated with Markers of Neutrophil Function and Gastrointestinal Disruption in Pilot Study of Co-Infection of ART-Treated SIVmac239+ Rhesus Macaques.

Nemphos S, Green H, Prusak J, Fell S, Goff K, Varnado M Viruses. 2024; 16(7.

PMID: 39066199 PMC: 11281461. DOI: 10.3390/v16071036.


Modeling and investigating malaria P. Falciparum and P. Vivax infections: Application to Djibouti data.

Souleiman Y, Ismail L, Eftimie R Infect Dis Model. 2024; 9(4):1095-1116.

PMID: 39006106 PMC: 11245922. DOI: 10.1016/j.idm.2024.06.003.


A hybrid transmission model for Plasmodium vivax accounting for superinfection, immunity and the hypnozoite reservoir.

Mehra S, Taylor P, McCaw J, Flegg J J Math Biol. 2024; 89(1):7.

PMID: 38772937 PMC: 11108905. DOI: 10.1007/s00285-024-02088-7.


Persistent and multiclonal malaria parasite dynamics despite extended artemether-lumefantrine treatment in children.

Goodwin J, Kajubi R, Wang K, Li F, Wade M, Orukan F Nat Commun. 2024; 15(1):3817.

PMID: 38714692 PMC: 11076639. DOI: 10.1038/s41467-024-48210-7.


References
1.
Koepfli C, Mueller I . Malaria Epidemiology at the Clone Level. Trends Parasitol. 2017; 33(12):974-985. PMC: 5777529. DOI: 10.1016/j.pt.2017.08.013. View

2.
Robinson L, Wampfler R, Betuela I, Karl S, White M, Li Wai Suen C . Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model. PLoS Med. 2015; 12(10):e1001891. PMC: 4624431. DOI: 10.1371/journal.pmed.1001891. View

3.
Ashley E, White N . The duration of Plasmodium falciparum infections. Malar J. 2014; 13:500. PMC: 4301960. DOI: 10.1186/1475-2875-13-500. View

4.
White M, Shirreff G, Karl S, Ghani A, Mueller I . Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria. Proc Biol Sci. 2016; 283(1827):20160048. PMC: 4822465. DOI: 10.1098/rspb.2016.0048. View

5.
Lover A, Coker R . Quantifying effect of geographic location on epidemiology of Plasmodium vivax malaria. Emerg Infect Dis. 2013; 19(7):1058-65. PMC: 3713979. DOI: 10.3201/eid1907.121674. View